statistiche ricercatore

Continente	#
NA - Nord America	1.188
AS - Asia	692
EU - Europa	642
SA - Sud America	120
Continente sconosciuto - Info sul continente non disponibili	88
AF - Africa	24
OC - Oceania	1
Totale	2.755

Nazione	#
US - Stati Uniti d'America	1.133
SG - Singapore	224
IT - Italia	204
CN - Cina	144
HK - Hong Kong	109
DE - Germania	90
BR - Brasile	80
VN - Vietnam	75
RU - Federazione Russa	74
SE - Svezia	50
IE - Irlanda	45
CA - Canada	42
GB - Regno Unito	39
BD - Bangladesh	31
AT - Austria	29
FR - Francia	20
IN - India	19
FI - Finlandia	18
KR - Corea	17
AR - Argentina	16
UA - Ucraina	16
TR - Turchia	13
DK - Danimarca	12
PL - Polonia	12
BE - Belgio	11
JP - Giappone	11
ID - Indonesia	10
ZA - Sudafrica	10
ES - Italia	8
VE - Venezuela	8
SA - Arabia Saudita	7
CO - Colombia	5
EC - Ecuador	5
MX - Messico	5
CL - Cile	4
IQ - Iraq	4
PK - Pakistan	4
DO - Repubblica Dominicana	3
HN - Honduras	3
MY - Malesia	3
NL - Olanda	3
TN - Tunisia	3
AE - Emirati Arabi Uniti	2
CH - Svizzera	2
EG - Egitto	2
GR - Grecia	2
KW - Kuwait	2
LT - Lituania	2
LY - Libia	2
MA - Marocco	2
NP - Nepal	2
UZ - Uzbekistan	2
AM - Armenia	1
AU - Australia	1
AZ - Azerbaigian	1
BA - Bosnia-Erzegovina	1
IL - Israele	1
JO - Giordania	1
KE - Kenya	1
KG - Kirghizistan	1
LA - Repubblica Popolare Democratica del Laos	1
LB - Libano	1
LK - Sri Lanka	1
LV - Lettonia	1
ME - Montenegro	1
MM - Myanmar	1
MT - Malta	1
MU - Mauritius	1
MZ - Mozambico	1
NI - Nicaragua	1
OM - Oman	1
PA - Panama	1
PE - Perù	1
PH - Filippine	1
PS - Palestinian Territory	1
PY - Paraguay	1
RO - Romania	1
SC - Seychelles	1
TH - Thailandia	1
ZW - Zimbabwe	1
Totale	2.667

Nome	#
RNA-seq is a valuable complement of conventional diagnostic tools in newly diagnosed AML patients	460
Long-term efficacy and safety of crizotinib in relapsed ALK positive lymphoma patients: clinical and biological correlates	457
Serum ferritin and liver features in a cohort of 15 patients affected by Gaucher disease	415
Case Report: Successful use of emapalumab in adult B-cell acute lymphoblastic leukemia experiencing severe neurotoxicity and hemophagocytic lymphohistiocytosis-like features after CAR-T cell therapy	315
Humoral and cellular immune response in patients with hematological disorders after two doses of BNT162b2 mRNA COVID-19 vaccine: A single-center prospective observational study (NCT05074706)	253
Validation of a new NGS-based myeloid panel in acute myeloid leukemia: A single-center experience	235
A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study	194
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes	188
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes	176
Prognostic Score for Myelodysplastic Syndromes Based on Molecular Evolution	62
Totale	2.755

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	78	0	17	25	9	0	1	5	1	2	7	4	7
2022/2023	171	13	22	19	20	16	21	10	7	15	8	14	6
2023/2024	169	10	7	16	18	23	48	23	2	12	3	0	7
2024/2025	388	14	27	30	21	39	18	23	4	26	61	51	74
2025/2026	1.212	160	65	88	174	129	52	198	42	84	87	50	83
2026/2027	171	70	101	0	0	0	0	0	0	0	0	0	0
Totale													2.755

Bicocca Open Archive